4D Molecular Therapeutics Chief Legal Officer Scott Bizily disposes of USD 22,317.75 in common shares
FDMT•Chief legal officer sells shares after option exercise
- Chief Legal Officer Scott Bizily exercised stock options in 4D Molecular Therapeutics on Sep. 16, 2026 for 1,635 shares at $4.14.
- He disposed of 1,635 shares the same day at $13.65.
- Bizily directly held 8,617 shares following the transactions.
